Effects of chronic octreotide treatment on renal changes during cirrhosis in rats

Hepatology

Volumn 29, Issue 5, 1999, Pages 1387-1395

  Jonassen, Thomas E N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; FUROSEMIDE; LITHIUM; OCTREOTIDE; POTASSIUM; SODIUM; VASOPRESSIN; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; COMMON BILE DUCT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HENLE LOOP; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SLOW RELEASE FORMULATION; SODIUM RETENTION; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0032902738     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290532     Document Type: Article

References (5)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen J, Rodes J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. HEPATOLOGY 1988;8:1151-1157.
2. Martin PY, Ohara M, Gines P, Xu DL, St John J, Niederberger M, Schrier RW. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998;101:235-242.
3. Wang S-S, Lee F-Y, Wu S-L, Hwu C-M, Chien C-H, Lee S-D, Tsai Y-T, et al. Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrotic rats. J Hepatol 1997;26:1128-1134.
4. Levy M. Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms. Am J Physiol 1977;233:F586-F592.
5. Wood LJ, Massie D, McLean J, Dudley FJ. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. HEPATOLOGY 1988;8:831-836.